Product Details

Cervarix Vaccine## (check composition)

Human papillomavirus bivalent (types 16 & 18) vaccine
0.5 mL
Suspension

ROA

Intramuscular

Applicant Name

Glaxo Smithkline Consumer Nigeria PLC

NRN

A6-0012

Status

Active


Composition

Each dose (0.5 mL) contains: Human Papillomavirus Type 16 L1 protein 20 mcg, , Human Papillomavirus Type 18 L1 protein 20 mcg, 3-O-desacyl-4' - Monophosphoryl Lipid A (MPL) 50 mcg, Aluminium Hydroxide, hydrated 0.5 mg Al3+ Excipients q.s.  

ATC Code

J07BM02  

Product Category

Vaccines and Biologics

Marketing Category

Prescription-only Medicine (POM)  

Packsize

1 x 0.5 mL (in pre-filled syringe/vial)  

Product Description

Suspension for Injection HUMAN PAPILLOMAVIRUS VACCINE TYPES 16 AND 18 0.5ml N/A Turbid white suspension in a pre-filled syringe + 1 needle SUSPENSION GLAXOSMITHKLINE PHARMACEUTICAL NIGERIA LTD. GlaxoSmithKline Biologicals S.A., 89, Rue de l'Institut, 1330 Rixensart, Belgium 03/12/2023 29/11/2028

Manufacturer Name

Glaxosmithkline Biologicals S.A

Manufacturer Country

BELGIUM  

Approval Date

2023-11-30  

Expiry Date

2028-11-29